As of June this year, based on Stryker's most recent financial report, the company's trailing twelve months EPS is $7.5. During 2024, SYK reported a per-share earnings of $7.86, which shows a decline compared to the EPS of $8.34 recorded in 2023. Stryker's EPS for the quarterly period ending on Mar 31, 2025 came in at $1.71.
The yearly earnings per share during 2024 was $7.86, a decline of 5.8% compared to $8.34 recorded in 2023. Over the quarter ending Mar 31, 2025, the earnings per share came in at $1.71, reflecting a 17.4% decline compared to the same quarter a year earlier. As of March 2025, the TTM EPS is $7.5. During 2023, the annual earnings per share was $8.34, representing an increase of 33.9% compared to 2022.
Stryker has recorded a decline in earnings per share of 17.4% in the past 12 months (YoY, quarterly). Across the past three years, the company had an average EPS annual growth rate of 14.1% per year. Stryker had an average annual EPS growth of 7.1% in the last five years. When assessed over a ten-year period, SYK's average EPS annual growth was 19.2%.
Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
---|---|---|---|---|
EW Edwards Lifesciences Corp | 10.95 | 202.2% | 42.5% | 33% |
CNMD CONMED Corp | 14.74 | 104.3% | 26.1% | 33.5% |
JNJ Johnson & Johnson | 17.06 | -57.9% | -9.7% | 0.4% |
MDT Medtronic plc | 26.28 | -2.1% | 1.1% | -4.2% |
WAT Waters Corp | 31.62 | -1.1% | -1.5% | 4.2% |
GMED Globus Medical Inc | 43.99 | -30.3% | -19.9% | -13.5% |
SYK Stryker Corp | 51.12 | -5.8% | 14.1% | 7.1% |
BSX Boston Scientific Corp | 73.2 | 16.7% | 22.2% | -17.9% |
BAX Baxter International Inc | N/A | -124.2% | N/A | N/A |
IART Integra Lifesciences Holdings Corp | N/A | -110.6% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.